O

Organogenesis Tech Stack

Regenerative medicine manufacturer scaling production and regulatory compliance

Biotechnology Research Canton, Massachusetts 501–1,000 employees Founded 1985 Public Company

Organogenesis manufactures advanced wound care and surgical biologics across a 501–1,000 person operation headquartered in Massachusetts. The tech stack is enterprise Microsoft (Office, Dynamics 365, Power BI, Access, SQL) paired with specialized manufacturing tools (CMMS, Documentum, AutoCAD), reflecting a manufacturing-heavy org: 22 of 46 active roles are in manufacturing. Active projects span cell culture assay development, bioprocess scale-up, and factory acceptance testing, while pain points cluster around production yield, capacity expansion, and regulatory audit compliance—the operational constraints of a scaled biotech manufacturer.

Tech Stack 15 technologies

Core StackAutoCAD Power BI Power Apps Power Platform Microsoft Office CMMS Documentum SQL DAX Excel Word PowerPoint Outlook Microsoft Access

AdoptingMicrosoft Dynamics 365

What Organogenesis Is Building

◆Challenges

Compliance with regulatory audits
Manufacturing efficiency improvements
Reducing system downtime
Meeting sales forecasts
Boost efficiency and reduce costs
Resource allocation challenges
Improving product yield
Increasing capacity
Reducing production costs
Remedying audit deficiencies

▲Active Projects

Cell culture assay development
Birth tissue donation program
Design and execute experiments to investigate hypotheses
Cross-functional histology projects
Bio-process scale-up
Evaluating new manufacturing systems
Factory acceptance testing
Build reporting and data collection systems
Build databases and sources for reporting
Complex data modeling and measure building

Hiring Activity

Minimal45 roles · 1 in 30d

Department

Manufacturing

22

Engineering

5

Sales

5

Ops

3

Support

3

Marketing

2

Quality

2

Construction

1

Seniority

Junior

18

Mid

12

Senior

10

Manager

3

Director

2

Notable leadership hires: Capital Projects Director

Company intelligence

Find more companies like Organogenesis by tech stack, pain points and active projects

Get started free

About Organogenesis

Organogenesis develops and manufactures regenerative medicine products for advanced wound care, surgical applications, and sports medicine. The company was founded in 1985 and operates as a public company. The product portfolio addresses soft tissue regeneration and orthopedic applications through bio-active wound healing and surgical biologics. Operations are centered on manufacturing scale, process improvement, and compliance across a 501–1,000 person team based in Canton, Massachusetts, with hiring activity in the United States and Peru. Current focus areas include bioprocess optimization, manufacturing system evaluation, and regulatory audit remediation.

HeadquartersCanton, Massachusetts

Company Size501–1,000 employees

Founded1985

Hiring MarketsUnited States, Peru

Frequently Asked Questions

What is Organogenesis's main business?

Organogenesis manufactures regenerative medicine products focused on advanced wound care, surgical biologics, and sports medicine applications. The company develops bio-active wound healing solutions and soft tissue regeneration products for healthcare providers.

Where is Organogenesis headquartered?

Organogenesis is headquartered in Canton, Massachusetts. The company was founded in 1985 and operates as a public company with 501–1,000 employees.

What countries does Organogenesis hire in?

Organogenesis actively hires in the United States and Peru. Current open roles total 46, with manufacturing representing 22 of those positions, indicating capacity expansion in production operations.